Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin

Table 3 Stepwise logistic regression analysis of factors significantly associated with HCV sustained virologic response (SVR) after combination therapy in 156 CHC patients

Dependent variable	Independent variable	Comparison	OR (95%CI1)		P
HCV SVR
	HCV genotypes	1b = 0	12.098	(0.02 - 0.19)	< 0.001
		Non-1b = 1
	Age	Per year increased	0.936	(0.890 - 0.998)	0.011
	HCV RNA level	High ( 200 000 IU/mL) = 0	3.131	(1.080 - 9.077)	0.036
	Low (< 200 000 IU/mL) = 1

¹CI: Confidence interval.